Laila S Tabatabai1, Joan Bloom2, Susan Stewart3, Deborah E Sellmeyer4. 1. 1 Division of Endocrinology, Houston Methodist Hospital, Houston, Texas. 2. 2 Department of Health Policy and Management, School of Public Health, University of California, Berkeley, California. 3. 3 Department of Public Health Sciences, School of Medicine, University of California, Davis, California. 4. 4 Division of Endocrinology, Gerontology, and Metabolism, Stanford University School of Medicine, Palo Alto, California.
Abstract
Background/Introduction/Objective: Premenopausal women treated for breast cancer are at high risk for bone loss. This trial examined the effects of a 1-year combined aerobic and resistance exercise program on bone mineral density (BMD) in women treated for premenopausal breast cancer. MATERIALS AND METHODS:Premenopausal women (n = 206) age ≤ 55 years at cancer diagnosis who were within two years of receiving adjuvant chemotherapy were randomized to a 12-month exercise program or a control group. BMD was measured by dual-energy X-ray absorptiometry at baseline and after 1 year; blood was drawn for skeletal markers. Change from baseline to end of study was compared within and between treatment groups using paired and unpaired t-tests. RESULTS:Lumbar spine BMD declined in both treatment groups with no significant difference between treatment groups (-0.008 ± 0.003 g/cm2 exercise vs. -0.014 ± 0.003 g/cm2 control, p = 0.24). However, among the women who did not lose lean mass during the study (n = 100, 54 control, 46 exercise), the exercise intervention prevented lumbar spine bone loss (0.001 ± 0.005 g/cm2 treatment group vs. -0.014 ± 0.005 g/cm2 control group, p = 0.03). Bone turnover markers decreased significantly in both groups with no differences between groups. CONCLUSIONS: Among women who maintained lean mass, our exercise intervention prevented bone loss; however, our intervention did not prevent bone loss among women who lost muscle mass. Additional investigation into exercise regimens that can prevent both bone and muscle loss may help prevent long-term consequences of premenopausal breast cancer treatment.
RCT Entities:
Background/Introduction/Objective: Premenopausal women treated for breast cancer are at high risk for bone loss. This trial examined the effects of a 1-year combined aerobic and resistance exercise program on bone mineral density (BMD) in women treated for premenopausal breast cancer. MATERIALS AND METHODS: Premenopausal women (n = 206) age ≤ 55 years at cancer diagnosis who were within two years of receiving adjuvant chemotherapy were randomized to a 12-month exercise program or a control group. BMD was measured by dual-energy X-ray absorptiometry at baseline and after 1 year; blood was drawn for skeletal markers. Change from baseline to end of study was compared within and between treatment groups using paired and unpaired t-tests. RESULTS: Lumbar spine BMD declined in both treatment groups with no significant difference between treatment groups (-0.008 ± 0.003 g/cm2 exercise vs. -0.014 ± 0.003 g/cm2 control, p = 0.24). However, among the women who did not lose lean mass during the study (n = 100, 54 control, 46 exercise), the exercise intervention prevented lumbar spine bone loss (0.001 ± 0.005 g/cm2 treatment group vs. -0.014 ± 0.005 g/cm2 control group, p = 0.03). Bone turnover markers decreased significantly in both groups with no differences between groups. CONCLUSIONS: Among women who maintained lean mass, our exercise intervention prevented bone loss; however, our intervention did not prevent bone loss among women who lost muscle mass. Additional investigation into exercise regimens that can prevent both bone and muscle loss may help prevent long-term consequences of premenopausal breast cancer treatment.
Entities:
Keywords:
bone density; bone loss; breast cancer; exercise; osteoporosis; premenopausal
Authors: W Demark-Wahnefried; B L Peterson; E P Winer; L Marks; N Aziz; P K Marcom; K Blackwell; B K Rimer Journal: J Clin Oncol Date: 2001-05-01 Impact factor: 44.544
Authors: T Saarto; H Sievänen; P Kellokumpu-Lehtinen; R Nikander; L Vehmanen; R Huovinen; H Kautiainen; S Järvenpää; H M Penttinen; M Utriainen; A S Jääskeläinen; A Elme; J Ruohola; T Palva; H Vertio; M Rautalahti; M Fogelholm; R Luoto; C Blomqvist Journal: Osteoporos Int Date: 2011-09-03 Impact factor: 4.507
Authors: R R Love; R B Mazess; H S Barden; S Epstein; P A Newcomb; V C Jordan; P P Carbone; D L DeMets Journal: N Engl J Med Date: 1992-03-26 Impact factor: 91.245